Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Currently, obicetrapib is in a Phase 2 open-label exploratory proof-of-concept clinical trial (NCT05161715)
Last Updated: 10/07/2025 For years, the solution to obesity was always simple: eat less and move more. That was until the introduction of GLP-1 weight loss treatments like Mounjaro, Wegovy, and Saxenda
, we recognize the unique challenges faced by individuals dealing with infertility and Polycystic Ovary Syndrome (PCOS)
GLP-1R/FGF21 dual agonists (e.g., Minwei Bios asset) are entering Phase 3 with a differentiated hepatic mechanism
The testing culture sounds reassuring until you look at what the labs find
US$ 20.65
US$ 29.71
US$ 23.07
US$ 24.98
US$ 28.78
